SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-20-004103
Filing Date
2020-06-02
Accepted
2020-06-02 20:06:33
Documents
1
Period of Report
2020-05-29

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 13031
  Complete submission text file 0001562180-20-004103.txt   14671
Mailing Address FIRST FLOOR, BLOCK 3, THE OVAL, SHELBOURNE ROAD, BALLSBRIDGE DUBLIN L2 00000
Business Address FIRST FLOOR, BLOCK 3, THE OVAL, SHELBOURNE ROAD, BALLSBRIDGE DUBLIN L2 00000 353 1 6699 020
AMARIN CORP PLC\UK (Issuer) CIK: 0000897448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AMARIN PHARMA, INC. 1430 ROUTE 6 BEDMINSTER NJ 07921
Business Address
THERO JOHN F (Reporting) CIK: 0001199637 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-21392 | Film No.: 20938650